BiotechTube
Home/NuVision Biotherapies/Roger Teasdale
RT

Roger Teasdale

Chairman

NuVision Biotherapies

Therapeutic Areas

OphthalmologyRegenerative Medicine

NuVision Biotherapies Pipeline

DrugIndicationPhase
OmnigenOcular surface wound healing (e.g., corneal defects, ulcers, dry eye disease)Commercial
OmniLenzSurgery-free ocular care (therapeutic contact lens)Commercial

Leadership Team at NuVision Biotherapies

NW
Noel Waters
Chief Operating Officer
TG
Tim Gray
Chief Financial Officer
DA
Dr. Andrew Hopkinson
Founder and Chief Scientific Officer
View full NuVision Biotherapies profile